Central to the pathogenesis of SM is the somatic KIT D816V mutation, which results in the constitutively activated ligand-independent transmembrane receptor kinase c-KIT and is present in 95% of cases [1]. The gene discussed is KIT; the disease is systemic mastocytosis.